Company: SNWV
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001628280-25-038937
Chunk: 3

Company: SANUWAVE Health, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 2
Chunk 3
---
,240 2,718 52%15,342 9,442 5,900 62%Gross margin %78%73%79%73%Operating expenses:General and administrative4,039 1,839 2,200 120%8,506 5,514 2,992 54%Selling and marketing1,674 1,034 640 62%3,205 2,266 939 41%Research and development194 195 (1)-1%402 358 44 12%Depreciation and amortization174 180 (6)-3%366 362 4 1%Operating income1,877 1,992 (115)-6%2,863 942 1,921 204%Other income (expense)(822)4,569 (5,391)-118%(7,484)1,091 (8,575)-786%Net income (loss)$1,055 $6,561 $(5,506)-84%$(4,621)$2,033 $(6,654)-327%

Revenue

Revenues for the three months ended June 30, 2025, were $10.2 million, compared to $7.2 million for the same period of 2024, an increase of $3.0 million or 42%. The increase in net sales was primarily driven by the growth in quantity of UltraMIST® disposables and systems sold as well as a strategic focus on price discipline. The quantity of UltraMIST® disposables sold increased by 29% in the three months ended June 30, 2025, as compared to the same period of 2024. The quantity of UltraMIST® systems sold increased by 61% in the three months ended June 30, 2025, as compared to the same period of 2024. Pricing of the UltraMIST® system and disposables also showed growth in the three months ended June 30, 2025, as compared to the same period of 2024; the average selling price of disposables increased 6% in the three months ended June 30, 2025, and the average selling price of systems increased 1% in the three months ended June 30, 2025. Revenue from UltraMIST® totaled 99% of total revenue in the three months ended June 30, 2025, and over